Drug Profile
OREX 1019
Alternative Names: OREX-1019Latest Information Update: 26 Sep 2023
Price :
$50
*
At a glance
- Originator University of Bath
- Developer Orexigen Therapeutics; University of Bath
- Class Cyclopropanes; Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Nociceptin receptor agonists; Opioid delta receptor antagonists; Opioid kappa receptor antagonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cocaine-related disorders
Most Recent Events
- 26 Sep 2023 Discontinued - Preclinical for Cocaine-related disorders in USA (unspecified route)
- 26 Sep 2023 Discontinued for Cocaine-related disorders in United Kingdom (unspecified route)
- 28 Dec 2020 No recent reports of development identified for preclinical development in Cocaine-related-disorders in USA